Sanofi to invest $500M in Toronto vaccine facility

Thursday April 12, 2018
Written by Manufacturing AUTOMATION
Apr. 12, 2018 - The federal and Ontario governments have announced an investment of up to $70 million toward Sanofi Pasteur Limited’s $500-million project to help establish what they say will be one of the world’s most advanced vaccine manufacturing facilities.

Sanofi Pasteur is the vaccine division of Sanofi, a global healthcare company and vaccine manufacturer.

The new 150,000-square-foot Bulk Biologics Facility, at the Connaught Campus in Toronto, Ont., is estimated to double the output of its vaccines by 2023 and launch the Canadian researched and developed pertussis - or whooping cough - vaccine into 30 new international markets.

Through this project, nearly 1,250 jobs will be created or maintained, says the company.

The FedDev Ontario contribution of $20 million is a repayable contribution through the Advanced Manufacturing Fund. The Government of Ontario is investing $50 million through the Jobs and Prosperity Fund.

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Events

Digital Industry USA
September 10-12, 2019
EMO Hannover 2019
September 16-21, 2019
Weidmuller Open House
September 17, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.